Cullinan Management, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Cullinan Management, Inc. | CGEM - NASDAQ |
$19.00-$20.00 | $21.00 | $42.00 | 11.9 million | 1/8/2021 |
| Morgan Stanley, SVB Leerink, Evercore ISI | ||||||
Co-Manager(s): HC Wainwright | ||||||
| Health Care | ||||||
Filing(s): Terms Added 2021-01-04 Filed 2020-12-18 | ||||||
Cullinan Management, Inc. Quote & Chart - Click for current quote - CGEM
IPO Boutique aggregates information on public companies and private companies, such as "CGEM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Cullinan Management, Inc. (adapted from Cullinan Management, Inc. prospectus):
They are a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CGEM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.